ALPN(Delisted)
Alpine ImmuneยทNASDAQ
--
--(--)
ALPN Profile
Alpine Immune Sciences, Inc.
A clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases
188 East Blaine Street, Suite 200, Seattle, WA 98102
--
Alpine Immune Sciences, Inc., formerly known as N30 Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on December 30, 2014. The company is a clinical-stage pharmaceutical company dedicated to the discovery and development of innovative, protein-based immunotherapies for the treatment of autoimmune and inflammatory diseases. The company's approach includes a proprietary scientific platform that translates innate immune system proteins into differentiated, multi-target therapies. The company is seeking to create best-in-class or best-in-class multifunctional immunotherapies through unique protein engineering technologies to improve outcomes for patients with serious diseases.
